Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bauman

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Head & Neck|September 29, 2020
Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcomeDouglas Y Lee, Jesty Abraham, Eric Ross, et al.
Journal of Palliative Medicine|November 27, 2024
End-of-Life Care in Hematology/Oncology FellowshipMadeline J Albert, Yang Liu, Asya Varshavsky, et al.
Journal of Palliative Medicine|September 1, 2025
A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship TrainingJessica R Bauman, Madeline Albert, Marcin Chwistek, et al.
Lung Cancer (Amsterdam, Netherlands)|November 2, 2024
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 22, 2020
Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare PatientsChase C Hansen, Brian Egleston, Brooke K Leachman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2025
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancerJessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Frontiers in Oncology|January 1, 2021
Development of a Web-Based Supportive Care Program for Patients With Head and Neck CancerCarolyn Y Fang, Thomas J Galloway, Brian L Egleston, et al.
Journal of Cancer Survivorship : Research and Practice|July 11, 2025
Medically tailored meals in lung cancer care: patient experiences from the NutriCare Clinical TrialCaroline E Owens, Laura Keaver, Divina Chandiramani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2021
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIsE Felip, A T Shaw, A Bearz, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Head & Neck|September 29, 2020
Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcomeDouglas Y Lee, Jesty Abraham, Eric Ross, et al.
Journal of Palliative Medicine|November 27, 2024
End-of-Life Care in Hematology/Oncology FellowshipMadeline J Albert, Yang Liu, Asya Varshavsky, et al.
Journal of Palliative Medicine|September 1, 2025
A Longitudinal, Palliative Care Educational Pilot in Hematology-Oncology Fellowship TrainingJessica R Bauman, Madeline Albert, Marcin Chwistek, et al.
Lung Cancer (Amsterdam, Netherlands)|November 2, 2024
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 22, 2020
Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare PatientsChase C Hansen, Brian Egleston, Brooke K Leachman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2025
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancerJessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Frontiers in Oncology|January 1, 2021
Development of a Web-Based Supportive Care Program for Patients With Head and Neck CancerCarolyn Y Fang, Thomas J Galloway, Brian L Egleston, et al.
Journal of Cancer Survivorship : Research and Practice|July 11, 2025
Medically tailored meals in lung cancer care: patient experiences from the NutriCare Clinical TrialCaroline E Owens, Laura Keaver, Divina Chandiramani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2021
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIsE Felip, A T Shaw, A Bearz, et al.
Pageof 11